September 28, 2020

The Niche

Knoepfler lab stem cell blog

Allan Robins

4 min read

By Heather Main What countries are doing disproportionately well given their size on their stem cell research? When reading through the ISSCR 2015 program you can understand why everyone wants to go to the US for their postdoc as it seems like most of the work being presented is US-based. In fact, this is more than true with 78 of 156 speakers being USA based, a straight 50% of the program. Coming in second is Germany with 11 speakers. Being an Aussie I wanted …Read More

1 min read

Allan Robins of Viacyte (pictured at left–sorry for the fuzzy image) and Paul Simmons of Mesoblast presented this morning at the CIRM Grantee Meeting. Both talks were outstanding. Robins went first. He started by saying how Viacyte had a productive pre-IND meeting with the FDA last year. I believe a target for them is to have IND in Q1 of 2014 and hopefully move to the clinical trials soon after. I gotta say I love Viacyte’s technology. Having a frozen product that then can …Read More